Jul 21, 2018 Canaccord Previews Biotech Catalysts In The Second Half: Neurological Drugs In Focus Canaccord Previews Biotech Catalysts In The Second Half: Neurological Drugs In FocusThe biotech space represents a gold mine of opportunity for investors to multiply their investment returns, courtesy of the volatility generated by ... read morePublished on 2018-07-21